{"schema_version":"secwatch.filing_event.v1","accession":"0001438133-24-000166","form_type":"8-K","ticker":"TNDM","cik":"0001438133","company_name":"TANDEM DIABETES CARE INC","filed_at":"2024-06-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.429047+00:00","generated_at":"2026-06-01T02:47:04.416094+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Tandem Diabetes appoints Jean-Claude Kyrillos as EVP, COO effective June 21, 2024","bullets":["Kyrillos previously served as President of Diagnostics & Digital Solutions at Envista Holdings and held senior roles at Qualcomm Life, BD, and ResMed.","Annual base salary set at $450,203.73; target bonus of 60% of base salary (0-200% payout range) under Cash Bonus Plan.","Target long-term incentive of 400% of base salary in RSUs under the 2023 Long-Term Incentive Plan.","Severance agreement provides 18 months base salary continuation and full equity acceleration upon qualifying termination within change-of-control window.","Kyrillos holds a BA from Colgate University and an MBA from Harvard Business School."],"urls":{"canonical":"https://secwatch.observer/filing/0001438133-24-000166","json":"https://secwatch.observer/filing/0001438133-24-000166.json","markdown":"https://secwatch.observer/filing/0001438133-24-000166.md","text":"https://secwatch.observer/filing/0001438133-24-000166.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1438133/000143813324000166/0001438133-24-000166-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1438133/000143813324000166/tndm-20240619.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T02:47:04.416094+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ee69497432","claim":"Jean-Claude Kyrillos was appointed as Chief Operating Officer at TANDEM DIABETES CARE INC.","evidence_excerpt":"On June 19, 2024, the Board of Directors of Tandem Diabetes Care, Inc. (the “Company”) approved the appointment of Jean-Claude Kyrillos as Executive Vice President, Chief Operating Officer effective June 21, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1438133/000143813324000166/0001438133-24-000166-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Operating Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}